ArticleAbdominal radiology (New York)2026
LI-RADS TRA v2024 succeeds where RECIST and mRECIST fail: viability-based survival prediction in TACE-treated hepatocellular carcinoma.
Alisa Mohebbi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.